Solventum (SOLV) P/E (2024 - 2026)
Solventum (SOLV) P/E from Mar 26, 2024 to Jun 3, 2026. The TTM Solventum (SOLV) P/E is 9.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Solventum (SOLV)
| Year | P/E | Change |
|---|---|---|
| 2026 | 9.49 | +7.48% |
| 2025 | 8.83 | -62.93% |
| 2024 | 23.82 | N/A |
Comparison Solventum (SOLV) P/E with competitors
Solventum (SOLV) P/E is 9.49.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -97.64% |
| EMBC | Embecta Corp | 1.73 | -81.80% |
| ZJYL | Jin Medical International Ltd | 14.31 | +50.76% |
| PDEX | Pro-Dex Inc (co) | 17.38 | +83.16% |
| UTMD | Utah Medical Products Inc | 19.32 | +103.58% |
| ATR | Aptargroup Inc | 19.33 | +103.69% |
| RMD | Resmed Inc | 19.77 | +108.28% |
| MMSI | Merit Medical Systems Inc | 26.66 | +180.91% |
| ALGN | Align Technology Inc | 27.22 | +186.81% |
| COO | Cooper Companies Inc | 29.86 | +214.60% |
| STVN | Stevanato Group Spa | 29.88 | +214.85% |
| HOLX | Hologic Inc | 30.86 | +225.20% |
| LMAT | Lemaitre Vascular Inc | 34.86 | +267.29% |
| ALC | Alcon Inc | 40.20 | +323.57% |
| WST | West Pharmaceutical Services Inc | 41.29 | +335.11% |
| BDX | Becton Dickinson & Company | 44.61 | +370.01% |
| NEPH | Nephros Inc | 49.38 | +420.28% |
| ISRG | Intuitive Surgical Inc | 49.96 | +426.38% |
| NVST | Envista Holdings Corp | 56.43 | +494.61% |
| BAX | Baxter International Inc | 63.44 | +568.43% |
| ICUI | ICU Medical Inc | 74.28 | +682.71% |
| RGEN | Repligen Corp | 123.98 | +1206.28% |
| NNNN | Anbio Biotechnology - Class A | 223.63 | +2256.30% |
| WRBY | Warby Parker Inc - Class A | 292.87 | +2985.81% |